Bio-Rad Laboratories, Inc. is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. The company develops innovative, high-quality products that advance science and save lives. Its customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety, and environmental quality laboratories.

In March, Bio-Rad announced the launch of XP-Design Assay Salmonella Serotyping Solution, which is designed for the rapid detection and precise characterization of Salmonella species in food and environmental samples. Salmonella are gram-negative, rod-shaped bacilli that can cause diarrheal illness in humans. According to the U.S. Department of Agriculture, Salmonella is the most frequently reported cause of foodborne illness, with an estimated 1.4 million cases and more than 400 deaths annually in the United States.

Bio-Rad's assays use real-time polymerase chain reaction (PCR) technology to amplify and detect specific DNA sequences of target serotypes using fluorescent probes. Molecular serotyping of Salmonella allows for fast reaction and decision making during an outbreak event and can aid in the monitoring of specific serotypes throughout the food processing plant environment. The XP-Design Assay Salmonella Serotyping Solution provides a flexible approach to identify Salmonella serotypes after initial screening. The ready-to-use solution contains oligonucleotides. These primers and probes are specific to the target serotype, ensuring high specificity and reducing the risk of cross-reaction while delivering reliable results.

"With XP-Design Salmonella Serotyping Assays, we are setting a new standard for rapid and accurate food safety testing," according to Franck Edouard, Senior Marketing Director, Food Science Division, Bio-Rad Laboratories. "This launch underscores our commitment to providing advanced, reliable tools for detecting and identifying Salmonella, which are crucial for ensuring food safety and consumer confidence."

In late January, the company launched TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits. The new kits offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes, for use in either flow cytometry or fluorescent western blot experiments. The two-kit system provides researchers across academia, pharma, and biotech access to Bio-Rad’s StarBright Blue and StarBright Violet Dyes, employing Bio-Rad’s SpyTag and SpyCatcher technology to conjugate a dye to an antibody of choice. This enables the design and generation of bespoke, flexible high-plex panels for flow cytometry and easy multiplex integration for fluorescent western blots.

"The new TrailBlazer Tag and StarBright Dye Label Kits are designed for researchers who require greater flexibility in their multiplex experiments, providing multiple label color palette options and access to a select range of our unique StarBright Blue and StarBright Violet Dyes, with additional dyes to be added to the range in the near future," according to Hilary Mavor, Marketing Director of Bio-Rad’s Life Science Group. "With an easy-to-follow protocol and minimal hands-on time, the kits offer a simple process, resulting in user-independent, consistent, high-quality conjugated antibodies."

The company opened its facility at Hacienda in March 2013. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations. In 2024, it reported approximately 7,700 employees and $2.6 billion in revenues.

For more information about Bio-Rad Laboratories, Inc., please visit ww.bio-rad.com, www.linkedin.com/company/bio-rad, www.facebook.com/biorad, or www.instagram.com/bioradlabs.